FLASH SPRING SALE: 50% Off Premium Subscription >> FLASH SPRING SALE: 50% Off Premium >>
$5.79
+0.0600 (+1.05%)
At Close: Apr 29, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions Profile
There is currently no insider trading information for this ticker.

However, we invite you to learn more about this term and how to use this knowledge to benefit your trading strategy:
Click to get the best stock tips daily for free!

About Knight Therapeutics Inc.

Knight Therapeutics Inc., a specialty pharmaceutical company, develops, acquires, in-licenses, out-licenses, markets, and distributes pharmaceutical and consumer health products, and medical devices in Canada, Latin America, and internationally. It offers Nerlynx for extended adjuvant breast cancer and metastatic breast cancer; Tafasitamab for relapsed or refractory diffuse large B-cell lymphoma; Pemigatinib to treat metastatic cholangiocarcinoma... GUD.TO Profile

Golden Star

Ticker Date Change Price
DHT Apr 24 1.95% $11.28
MLI Apr 19 11.07% $52.28
LPLA Apr 19 4.31% $262.59
DOOR Apr 18 0.90% $131.39
PFLT Apr 18 1.78% $11.25
LNG Apr 17 3.12% $156.81
FCN Apr 16 2.83% $207.62
ELV Apr 16 5.33% $506.97
AKR Apr 05 6.47% $16.53
ITCI Apr 05 5.64% $68.44
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT